Conjugating cells were subjected to transfection by electroporation using a Gene Pulser II (Bio-Rad, Hercules, CA) as described previously (Iwamoto et al., 2014 (link), 2015 (link)). The resulting cell suspension was cultivated for 18 h and then treated with paromomycin sulfate (Sigma-Aldrich, St Louis, MO) at 120 µg/ml when using pIGF1, pIGF1C, pEGFP-neo4 and p2xmNeon_6xmyc_Neo4 vectors, or puromycin dihydrochloride (Fermentek, Jerusalem, Israel) at 200 µg/ml when using a pmCherry-pur4 vector. Cadmium chloride was also added at 0.5 µg/ml to induce the expression of drug-resistant genes for pEGFP-neo4, p2xmNeon_6xmyc_Neo4, and pmCherry-pur4 vectors. Resistant cells usually appeared within a few days after the drug was added. We checked that at least five independent clones (i.e. grown in five different wells) exhibited the same intracellular localization of each GFP–Nup.
Free full text: Click here